Candel Therapeutics Inc.

CADL | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.21

+$0.36 (+3.32%)

At close: Sep 21, 2026, 4:00 PM ET

$11.15

-$0.06 (-0.54%)

Pre-market: Sep 22, 2026, 8:34 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	n/a	n/a	n/a	125K	125K	125K
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	125K	125K	125K
Operating Income	-48.27M	-33.37M	-38.39M	-34.67M	-25.73M	-13.81M
Interest Income	3.92M	1.09M	2.08M	1.22M	n/a	111K
Pretax Income	-38.18M	-55.18M	-37.94M	-18.79M	-36.12M	-17.68M
Net Income	-38.18M	-55.18M	-37.94M	-18.79M	-36.12M	-17.68M
Selling & General & Admin	17.77M	14.06M	13.89M	14.06M	10.67M	5.18M
Research & Development	30.5M	19.31M	24.51M	20.79M	15.18M	8.75M
Other Expenses	n/a	n/a	n/a	-48K	n/a	n/a
Operating Expenses	48.27M	33.37M	38.39M	34.8M	25.85M	13.94M
Interest Expense	2.12M	2.09M	2.6M	1.71M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	48.27M	33.37M	38.39M	34.8M	25.85M	13.94M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	52.96M	31.68M	28.94M	28.82M	18.87M	18.71M
Shares Outstanding (Diluted)	52.96M	31.68M	28.94M	28.82M	18.87M	18.71M
EPS (Basic)	-0.72	-1.74	-1.31	-0.10	-1.91	-1.18
EPS (Diluted)	-0.72	-1.74	-1.31	-0.10	-1.91	-1.18
EBITDA	-35.22M	-52.1M	-34.38M	-16.31M	-36.12M	-13.1M
EBIT	-36.06M	-53.09M	-35.34M	-17.09M	-36.12M	-13.19M
Depreciation & Amortization	845K	990K	960K	778K	n/a	91K